VISIOPHARM A/S: Financial statements 2014
CVR: 26186676
Source: annual report 2014, Danish Business Authority
01/10/2013 – 30/09/2014
VISIOPHARM A/S (CVR 26186676) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 9,282,806 and a net result of DKK 1,064,445 compared with DKK -796,604 the year before. That is an increase of 45.9% compared with the year before. Equity in the 2014 report amounted to DKK 6,585,691. The solvency ratio was 52.6%.
- Gross Profit
- DKK 9,282,806
- Profit/Loss
- DKK 1,064,445
- Equity
- DKK 6,585,691
- Total Assets
- DKK 12,515,649
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 9.3M | 1.1M | 6.6M | - |
| 2013 | - | 6.4M | -797K | 5.5M | - |
| 2012 | - | 7.3M | -958K | 5.5M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
VISIOPHARM A/S has published its annual report for 2013. Gross profit came to DKK 6,364,341, and the net result was DKK -796,604.
About VISIOPHARM A/S
VISIOPHARM A/S is a Danish company of the type Aktieselskab based in Hørsholm, founded in 2001. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The company was previously named VISIOPHARM ApS. The management consists of Johan Doré Hansen and Michael Grunkin. The board consists of Evis Hursever (chair), Andrew James Thomson and Per Fredrik Thorell. The company is owned by Neptune Denmark Holdco ApS. The company has 56 employees (2026). In 2025, the company reported revenue of DKK 130,617,000 and a net result of DKK -17,223,000 compared with DKK -17,363,000 the year before. Equity in the 2025 report amounted to DKK -4,949,000.